Knee Osteoarthritis
Conditions
Interventions
Experimental group:PEMFs+sham drug
Control group:celecoxib+sham PEMFs
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
Male
Age
40 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Aged >=40 years old; 2. Patients diagnosed with knee arthritis (according to the "Guidelines for the Diagnosis and Treatment of Osteoarthritis (2018 Edition)" by the Orthopaedic Branch of the Chinese Medical Association and the diagnostic criteria for knee osteoarthritis formulated by the American College of Rheumatology in 2012; 3. Kellgren-Lawrence grading of knee joint 2-3; 4. NRS pain numerical score 4-6 points; 5. No obvious deformity; 6. Not participating in other clinical trials; 7. Can walk independently; 8. No recent surgery is considered; 9. Understand and sign the content of the informed consent form.
Exclusion criteria
Exclusion criteria: 1. No other joint diseases; 2. Knee replacement surgery or intracavitary injection therapy (within 6 months); 3. Diagnosed with rheumatoid arthritis or suspected other pathological conditions of the knee joint; 4. Previous use of PEMFs; 5. Unstable condition, suffering from mental illness such as depression and anxiety; 6. Have taken NSAIDs, opioids, amino acid glucose or other analgesics one week before enrollment; 7. Patients with intolerance to analgesics such as acetaminophen and NSAIDs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Western Ontarioand McMaster Universities for pain and physical function; | — |
Secondary
| Measure | Time frame |
|---|---|
| digital pain score;Quality of life score;The Western Ontarioand McMaster Universities for stiffness;6 Mimute-Walking Test; | — |
Countries
China
Contacts
Public ContactHe Chengqi
West China Hospital of Sichuan University
Outcome results
None listed